NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Skye Bioscience Inc (PINK: EMBI)

 
EMBI Technical Analysis
2
As on 11th Mar 2022 EMBI STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.76 & Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EMBISTOCK Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month -0.02 -33.33
Volume 1004174 1 Year 0.00 0.00
52 Week High 10.14 | 52 Week Low 0.03
 
PINK USA Most Active Stocks
TXGE 2496.74 -1.63%
CYBL 0.01 %
CLNV 0.02 0.00%
WRFX 0.01 %
AMXVF 1.05 10.53%
VDRM 0.01 %
AABB 0.03 0.00%
ICBU 0.01 %
NCRA 1.02 14.61%
HTZZ 24.68 1.52%
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
GPGC 0.40 3900.00%
JZRIF 0.15 1400.00%
GSTX 0.10 900.00%
NZERD 0.36 800.00%
MMCWF 0.07 600.00%
MRGO 4.50 350.00%
TDCH 0.60 275.00%
 
PINK USA Top Losers Stocks
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
FFVWF 0.01 -94.12%
PTHIF 0.10 -90.91%
PTHIF 0.10 -90.91%
GFDV 0.01 -88.89%
FSEI 0.01 -87.50%
TGMR 0.04 -84.00%
MINRF 0.05 -82.14%
KIRY 0.02 -80.00%
 
 
EMBI
Daily Charts
EMBI
Intraday Charts
Whats New @
Bazaartrend
EMBI
Free Analysis
 
EMBI Important Levels Intraday
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
 
EMBI Forecast December 2024
4th UP Forecast0.12
3rd UP Forecast0.09
2nd UP Forecast0.08
1st UP Forecast0.06
1st DOWN Forecast0.02
2nd DOWN Forecast0
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.04
 
EMBI Weekly Forecast
4th UP Forecast0.06
3rd UP Forecast0.05
2nd UP Forecast0.05
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.02
 
EMBI Forecast2024
4th UP Forecast19.54
3rd UP Forecast13.29
2nd UP Forecast9.42
1st UP Forecast5.56
1st DOWN Forecast-5.48
2nd DOWN Forecast-9.34
3rd DOWN Forecast-13.21
4th DOWN Forecast-19.46
 
 
EMBI Other Details
Segment EQ
Market Capital 22506660.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EMBI Address
EMBI
 
EMBI Latest News
 
Your Comments and Response on Skye Bioscience Inc
 
EMBI Business Profile
Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California. Address: 5910 Pacific Center Boulevard, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service